Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core Scientific Inc (CORZ) vs Goldman Sachs Group Inc (GS) Price & Performance

Core Scientific IncTrade
Goldman Sachs Group IncTrade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs Goldman Sachs Group Inc — how do they compare? Core Scientific Inc trades at $21.04 (market cap $6.35B), while Goldman Sachs Group Inc trades at $1,042.62 (market cap $301.19B). The key difference: Goldman Sachs Group Inc is far larger — about 47.4× Core Scientific Inc's market cap, and Goldman Sachs Group Inc pays a 1.93% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.

CORZGS
Market Cap
$6.35B$301.19B
Sector
TechnologyFinancials
52-Week High
$29.16$1.15K
52-Week Low
$13.55$715.95
Enterprise Value
$8.88B
Volume
2,592,735
Dividend Yield
1.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core Scientific Inc

CORZ trades at $21.30, up 9.57% in the last 24 hours, showing strong momentum despite a bearish technical signal. The stock faces fundamental challenges with a net income margin of -324.9% and negative EPS misses, but recent developments include a significant partnership with AMD for up to 2.5 gigawatts of data center capacity, potentially driving future revenue growth. Analyst sentiment remains overwhelmingly positive with 86% buy ratings and a consensus price target of $35.88.

The outlook for CORZ hinges on executing its AI infrastructure strategy, with the AMD deal offering substantial upside if successfully monetized. Key risks include persistent cash burn, competitive pressures, and reliance on long-term contracts. Investors should weigh the high growth potential against the current lack of profitability and volatile stock performance.

Goldman Sachs Group Inc

Goldman Sachs (GS) trades at $1,034.51, down 0.49% on the day, with a neutral technical signal and strong fundamental performance. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $20.98 surpassing the $14.47 estimate. Revenue growth is robust, rising to $58.28 billion in 2025, and net income margin expanded to 31.68%. The company is positioned to benefit from a surge in investment banking activity, including leading high-profile IPOs like Anthropic.

The outlook is positive given earnings momentum and strategic positioning in key deals, but risks include volatile cash flows and high leverage. Analyst consensus is a Buy with a $1,160 price target, implying potential upside. Investors should weigh strong profitability against macroeconomic sensitivity and balance sheet pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

Read more on CORZ

About Goldman Sachs Group Inc

The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.

Read more on GS